Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
10 03 2021
Historique:
received: 27 01 2021
revised: 05 03 2021
accepted: 06 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 15 9 2021
Statut: epublish

Résumé

The antigenic variability of influenza presents many challenges to the development of vaccines and immunotherapeutics. However, it is apparent that there are epitopes on the virus that have evolved to remain largely constant due to their functional importance. These more conserved regions are often hidden and difficult to access by the human immune system but recent efforts have shown that these may be the Achilles heel of the virus through development and delivery of appropriate biological drugs. Amongst these, single domain antibodies (sdAbs) are equipped to target these vulnerabilities of the influenza virus due to their preference for concave epitopes on protein surfaces, their small size, flexible reformatting and high stability. Single domain antibodies are well placed to provide a new generation of robust analytical reagents and therapeutics to support the constant efforts to keep influenza in check.

Identifiants

pubmed: 33802072
pii: biom11030407
doi: 10.3390/biom11030407
pmc: PMC8001348
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Influenza Vaccines 0
Single-Domain Antibodies 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2019 Nov 4;9(1):15899
pubmed: 31685871
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4586-91
pubmed: 16537393
Antibodies (Basel). 2019 Feb 10;8(1):
pubmed: 31544820
Immunotechnology. 1998 Jun;4(1):1-20
pubmed: 9661810
Structure. 2020 Oct 6;28(10):1114-1123.e4
pubmed: 32610044
Nat Med. 2019 Feb;25(2):212-220
pubmed: 30692696
Sci Transl Med. 2013 May 29;5(187):187ra72
pubmed: 23720583
Am J Public Health. 2013 Mar;103(3):e43-51
pubmed: 23327249
Elife. 2016 Jul 19;5:
pubmed: 27434673
Nature. 1993 Jun 3;363(6428):446-8
pubmed: 8502296
Influenza Other Respir Viruses. 2018 Mar;12(2):195-201
pubmed: 29356318
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17040-5
pubmed: 23027945
Nat Biotechnol. 2013 Jul;31(7):647-52
pubmed: 23728362
BioDrugs. 2009;23(2):93-109
pubmed: 19489651
J Virol. 2014 Dec;88(23):13580-92
pubmed: 25210195
Nat Biotechnol. 2007 Dec;25(12):1421-34
pubmed: 18066039
Sci Transl Med. 2013 Aug 28;5(200):200ra114
pubmed: 23986398
Antiviral Res. 2013 Mar;97(3):318-28
pubmed: 23274786
Curr Opin Virol. 2015 Apr;11:113-21
pubmed: 25846699
Vaccine. 2010 Jul 12;28(31):4895-902
pubmed: 20553769
PLoS One. 2008;3(12):e3942
pubmed: 19079604
Antiviral Res. 2013 Nov;100(2):567-74
pubmed: 24091204
Nat Microbiol. 2016 Jun 20;1(8):16080
pubmed: 27573105
Int J Cancer. 2002 Mar 20;98(3):456-62
pubmed: 11920600
J Infect Dis. 2011 Dec 15;204(12):1879-85
pubmed: 21998477
Handb Exp Pharmacol. 2008;(181):343-73
pubmed: 18071953
Viruses. 2019 Apr 30;11(5):
pubmed: 31052339
Nature. 1982 Mar 11;296(5853):115-21
pubmed: 6174870
Nanoscale Res Lett. 2014 Sep 26;9(1):528
pubmed: 25328501
mBio. 2016 Dec 13;7(6):
pubmed: 27965447
MAbs. 2018 Aug/Sep;10(6):815-826
pubmed: 29916758
Science. 2012 Sep 14;337(6100):1343-8
pubmed: 22878502
Cell. 2016 Jul 28;166(3):596-608
pubmed: 27453466
Nature. 2012 Sep 27;489(7417):526-32
pubmed: 22982990
Biochem Biophys Res Commun. 2009 Jul 17;385(1):118-22
pubmed: 19410554
Protein Sci. 2005 Nov;14(11):2901-9
pubmed: 16199666
Trends Microbiol. 2016 Dec;24(12):933-943
pubmed: 27751627
Science. 2009 Apr 10;324(5924):246-51
pubmed: 19251591
PLoS One. 2011;6(12):e28309
pubmed: 22164266
J Clin Invest. 2016 Apr 1;126(4):1482-94
pubmed: 26950424
Protein Eng Des Sel. 2018 Jul 1;31(7-8):267-275
pubmed: 30053276
J Mol Biol. 2001 Jul 13;310(3):591-601
pubmed: 11439026
J Mol Biol. 2018 Oct 19;430(21):4369-4386
pubmed: 30205092
J Immunol. 2011 Apr 1;186(7):4331-9
pubmed: 21357542
Curr Opin Immunol. 2015 Aug;35:113-22
pubmed: 26183209
Immunol Cell Biol. 2020 Apr;98(4):253-263
pubmed: 31914207
Vaccine. 2016 Oct 26;34(45):5442-5448
pubmed: 27622299
Cell Rep. 2017 Sep 19;20(12):2935-2943
pubmed: 28930686
Nat Microbiol. 2017 Oct;2(10):1415-1424
pubmed: 28827718
Nat Rev Microbiol. 2018 Jan;16(1):47-60
pubmed: 29081496
Mol Immunol. 2000 Aug;37(10):579-90
pubmed: 11163394
Science. 2010 Apr 16;328(5976):357-60
pubmed: 20339031
Nat Commun. 2017 Feb 13;8:14158
pubmed: 28194013
Antiviral Res. 2013 Mar;97(3):245-54
pubmed: 23274623
Science. 2013 Nov 22;342(6161):976-9
pubmed: 24264991
Proteins. 2018 Jul;86(7):697-706
pubmed: 29569425
J Transl Med. 2014 Dec 20;12:352
pubmed: 25526777
J Virol. 2015 Mar;89(5):2792-800
pubmed: 25540369
Science. 2011 Aug 12;333(6044):843-50
pubmed: 21737702
Nat Med. 2014 Feb;20(2):143-51
pubmed: 24412922
Biochim Biophys Acta. 2011 Feb;1808(2):522-9
pubmed: 20451491
Nat Struct Mol Biol. 2009 Mar;16(3):265-73
pubmed: 19234466
Front Immunol. 2020 May 29;11:627
pubmed: 32547534
J Virol. 2019 Apr 3;93(8):
pubmed: 30700609
PLoS One. 2014 Aug 01;9(8):e103294
pubmed: 25084445
Nat Commun. 2011 Dec 20;2:599
pubmed: 22186895
Nat Immunol. 2009 Jun;10(6):573-8
pubmed: 19448659
Cell. 2016 Jul 28;166(3):609-623
pubmed: 27453470
Front Immunol. 2017 Oct 02;8:1234
pubmed: 29038656
Virology. 2004 Aug 1;325(2):287-96
pubmed: 15246268
PLoS Pathog. 2014 May 01;10(5):e1004103
pubmed: 24788925
Nature. 2007 Feb 15;445(7129):732-7
pubmed: 17301785
J Transl Med. 2014 Dec 10;12:343
pubmed: 25496223
Mol Ther Nucleic Acids. 2020 Jun 5;20:777-787
pubmed: 32438313
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Nat Med. 2010 Dec;16(12):1389-91
pubmed: 21135852
Science. 2018 Nov 2;362(6414):598-602
pubmed: 30385580
Nat Rev Drug Discov. 2020 Apr;19(4):239-252
pubmed: 32060419
Virology. 1990 Mar;175(1):59-68
pubmed: 2309452
Mol Immunol. 2013 Jan;53(1-2):24-34
pubmed: 22784991
Nat Med. 2004 Aug;10(8):871-5
pubmed: 15247913
PLoS One. 2017 Apr 19;12(4):e0175733
pubmed: 28423025
Nature. 2020 Jul;583(7814):150-153
pubmed: 32461688
J Virol. 2014 Aug;88(15):8278-96
pubmed: 24829341
Science. 2011 Aug 12;333(6044):850-6
pubmed: 21798894
Nucleic Acids Res. 2017 Jan 4;45(D1):D466-D474
pubmed: 27679478
Antiviral Res. 2008 Nov;80(2):168-77
pubmed: 18598723
Anal Chem. 2011 Jun 15;83(12):4729-37
pubmed: 21591780
Vaccine. 2017 Sep 5;35(37):5011-5018
pubmed: 28774565
Anal Biochem. 2016 May 1;500:66-72
pubmed: 26450565
Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):178-83
pubmed: 19026455
Vaccine. 2007 Sep 28;25(39-40):6852-62
pubmed: 17719149
Biosens Bioelectron. 2013 May 15;43:412-8
pubmed: 23356997
Nature. 1989 Oct 12;341(6242):544-6
pubmed: 2677748
Front Immunol. 2019 Dec 12;10:2920
pubmed: 31921179
J Immunol. 1997 Feb 1;158(3):1222-30
pubmed: 9013963
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):5986-91
pubmed: 18413603
Annu Rev Immunol. 2013;31:705-42
pubmed: 23330954
Vaccine. 2010 Jan 8;28(3):759-66
pubmed: 19857452
Vaccine. 2010 Aug 16;28(36):5774-84
pubmed: 20621113
PLoS One. 2016 Oct 14;11(10):e0164296
pubmed: 27741319
J Virol. 2013 Jun;87(12):7149-54
pubmed: 23552413
Expert Rev Vaccines. 2010 Nov;9(11):1325-41
pubmed: 21087110
J Clin Invest. 2016 Feb;126(2):605-10
pubmed: 26731473
J Virol. 1993 May;67(5):2552-8
pubmed: 7682624
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17736-41
pubmed: 19004788
Nat Microbiol. 2019 Feb;4(2):306-315
pubmed: 30478290
Pharmacol Ther. 2017 Jan;169:47-56
pubmed: 27373507
Arch Med Res. 2009 Nov;40(8):673-6
pubmed: 20304255
Antiviral Res. 2011 Dec;92(3):389-407
pubmed: 21939690
PLoS One. 2011 Apr 01;6(4):e17665
pubmed: 21483777
Nat Commun. 2014 Apr 10;5:3614
pubmed: 24717798
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):445-50
pubmed: 24335589
Curr Opin Biotechnol. 2002 Dec;13(6):603-8
pubmed: 12482521
Annu Rev Biochem. 2000;69:531-69
pubmed: 10966468
N Engl J Med. 2006 Feb 23;354(8):785-8
pubmed: 16495389
Mol Immunol. 1997 Nov-Dec;34(16-17):1121-31
pubmed: 9566760
Int J Nanomedicine. 2019 Nov 29;14:9337-9349
pubmed: 31819435
Sci Rep. 2021 Feb 4;11(1):3126
pubmed: 33542302
Cell Host Microbe. 2014 May 14;15(5):644-51
pubmed: 24832457
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17121-6
pubmed: 18957538
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7385-90
pubmed: 19372381
Cell Rep. 2017 Apr 11;19(2):413-424
pubmed: 28402862
J Mol Biol. 2017 Aug 18;429(17):2694-2709
pubmed: 28648617
Anal Chem. 2018 May 1;90(9):5671-5677
pubmed: 29634235
Vaccine. 2014 Apr 17;32(19):2188-97
pubmed: 24613520
Vaccine. 2018 May 17;36(21):2937-2945
pubmed: 29699789
Influenza Other Respir Viruses. 2016 Sep;10(5):354-60
pubmed: 27426005
Nat Microbiol. 2019 Dec;4(12):2035-2038
pubmed: 31358984
J Infect Dis. 2019 Apr 8;219(Suppl_1):S62-S67
pubmed: 30715353
J Virol. 2016 Jan 13;90(7):3496-505
pubmed: 26764003
J Infect Dis. 2011 Apr 15;203(8):1063-72
pubmed: 21450996
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12444-9
pubmed: 15304650
Mol Immunol. 2008 Jul;45(12):3477-89
pubmed: 18023478
Nat Rev Drug Discov. 2020 Jun;19(6):427
pubmed: 32494049
PLoS One. 2013 Dec 11;8(12):e80034
pubmed: 24348996
Virol J. 2009 Dec 21;6:224
pubmed: 20025741
FEBS Lett. 1997 Sep 15;414(3):521-6
pubmed: 9323027
Front Cell Infect Microbiol. 2020 Apr 29;10:181
pubmed: 32411619
Adv Virus Res. 2020;106:1-38
pubmed: 32327145

Auteurs

Andrew Tung Yep (A)

Biotherapeutics Division, National Institute for Biological Standards and Control (NIBSC), Potters Bar, Hertfordshire EN6 3QG, UK.
Division of Infection and Immunity, University College London, London WC1E 6BT, UK.

Yasu Takeuchi (Y)

Division of Infection and Immunity, University College London, London WC1E 6BT, UK.
Advanced Therapies Division, NIBSC, Potters Bar, Hertfordshire EN6 3QG, UK.

Othmar G Engelhardt (OG)

Division of Virology, NIBSC, Potters Bar, Hertfordshire EN6 3QG, UK.

Simon E Hufton (SE)

Biotherapeutics Division, National Institute for Biological Standards and Control (NIBSC), Potters Bar, Hertfordshire EN6 3QG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH